The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis by a study of Randomized, Double Blind, Placebo-Controlled, Parallel Group.
The objective is to evaluate the effects on biomarkers and safety of BGS in postmenopausal patients with osteoporosis.